PBYI
Puma Biotechnology Inc
NASDAQ: PBYI · HEALTHCARE · BIOTECHNOLOGY
$7.08
+0.29% today
Updated 2026-06-05
Market cap
$358.84M
P/E ratio
14.69
P/S ratio
1.58x
EPS (TTM)
$0.48
Dividend yield
—
52W range
$3 – $8
Volume
0.3M
Puma Biotechnology Inc (PBYI) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$7.08
12-Month target
$4.87
2030 Target
—
Intrinsic (DCF)
$21.87
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 0.29% (capped 20%) · P/E: 14.69x (capped 25x) · Margin: 10.70%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.